logo-loader

ProNAi Therapeutics

Receive alerts
Market:
NASDAQ
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

ProNAi Therapeutics, Inc. is a clinical-stage oncology company. The Company develops and commercializes a portfolio of therapeutics based on its deoxyribonucleic acid interference (DNAi) technology platform for patients with cancer and hematological diseases.